BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3538368)

  • 1. Cerebrospinal fluid beta-2-microglobulin: a reliable index of leukaemic infiltration of central nervous system.
    Storti S; Pagano L; Marra R; Teofili L; Ricerca BM; Leone G; Bizzi B
    Scand J Haematol; 1986 Oct; 37(4):301-5. PubMed ID: 3538368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta 2-microglobulin, lysozyme and lactoferrin in cerebrospinal fluid in patients with lymphoma or leukaemia: relationship to CNS involvement and the effect of prophylactic intrathecal treatment with methotrexate.
    Oberg G; Hällgren R; Venge P
    Br J Haematol; 1987 Jul; 66(3):315-22. PubMed ID: 3304392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid protein findings during prophylaxis and treatment of neuromeningosis in leukaemic patients.
    Marra R; Pagano L; Storti S; Massaro A; Teofili L; Carbone G; Leone G
    Scand J Clin Lab Invest; 1987 Dec; 47(8):765-9. PubMed ID: 3432998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement.
    Hansen PB; Kjeldsen L; Dalhoff K; Olesen B
    Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid B2-microglobulin levels in meningeal involvement by malignancy.
    Jeffery GM; Frampton CM; Legge HM; Hart DN
    Pathology; 1990 Jan; 22(1):20-3. PubMed ID: 2194155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of cerebrospinal fluid sialic acid concentration in children with central nervous system leukemia.
    Asami T; Tanaka A; Gunji T; Sakai K; Asami K
    Acta Paediatr Scand; 1987 Mar; 76(2):260-5. PubMed ID: 3296627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta 2-microglobulin levels in cerebrospinal fluid of children with leukemia and lymphoma.
    Pudek MR; Chan KW; Rogers PC; Teasdale JM
    Clin Biochem; 1985 Jun; 18(3):180-3. PubMed ID: 3888445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CSF levels and diagnostic utility of cerebrospinal fluid beta2-microglobulin].
    Caudie C; Bancel J; Dupont M; Matanza D; Poitevin F; Honnorat J
    Ann Biol Clin (Paris); 2005; 63(6):631-7. PubMed ID: 16330382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of central nervous system metastasis with cerebrospinal fluid beta-2-microglobulin.
    Koch TR; Lichtenfeld KM; Wiernik PH
    Cancer; 1983 Jul; 52(1):101-4. PubMed ID: 6189578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance and limits of cerebrospinal fluid beta-2-microglobulin measurement in course of acute lymphoblastic leukemia.
    Musto P; Tomasi P; Cascavilla N; Ladogana S; La Sala A; Melillo L; Nobile M; Castoldi G; Carotenuto M
    Am J Hematol; 1988 Aug; 28(4):213-8. PubMed ID: 3046340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of cerebrospinal fluid beta 2-microglobulin determination in central nervous system leukemia].
    Zhang HZ; Ye X; Sun ZG
    Zhonghua Nei Ke Za Zhi; 1989 May; 28(5):262-4, 313. PubMed ID: 2680338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beta 2-microglobulin content of the cerebrospinal fluid in neurological disease.
    Starmans JJ; Vos J; van der Helm HJ
    J Neurol Sci; 1977 Aug; 33(1-2):45-9. PubMed ID: 71341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unreliability of beta-2-microglobulin in early detection of central nervous system relapse in acute lymphoblastic leukemia.
    Nagelkerke AF; van Kamp GJ; Veerman AJ; de Waal FC
    Eur J Cancer Clin Oncol; 1985 Jun; 21(6):659-63. PubMed ID: 3894031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid beta-2-microglobulin level as marker of central nervous system involvement in lymphoma.
    Pagano L; Marra R; Storti S; De Stefano V; Bizzi B
    Haematologia (Budap); 1986; 19(2):121-5. PubMed ID: 3530906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination.
    Mavlight GM; Stuckey SE; Cabanillas FF; Keating MJ; Tourtellotte WW; Schold SC; Freireich EJ
    N Engl J Med; 1980 Sep; 303(13):718-22. PubMed ID: 6157089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid immunoglobulins and beta 2-microglobulin in lymphoproliferative and other neoplastic diseases of the central nervous system.
    Ernerudh J; Olsson T; Berlin G; von Schenck H
    Arch Neurol; 1987 Sep; 44(9):915-20. PubMed ID: 3304227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of CNS leukemia in childhood. An outline of current concepts.
    Pochedly C
    Clin Pediatr (Phila); 1972 Sep; 11(9):503-8. PubMed ID: 5073799
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurement of beta-2-microglobulin in human cerebrospinal fluid by ELISA technique.
    Bjerrum OW; Lage S; Hansen OE
    Acta Neurol Scand; 1986 Sep; 74(3):177-80. PubMed ID: 3538752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Involvement of CNS in leukaemia and lymphomas--CSF meningeosis and immunocytochemical phenotyping].
    Lehmitz R; Pahnke J
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S37-8. PubMed ID: 19685390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system relapse surveillance by serial beta 2-microglobulin measurements in childhood acute lymphoblastic leukemia.
    Clausen N; Ibsen KK
    Acta Paediatr Scand; 1984 Nov; 73(6):848-54. PubMed ID: 6395626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.